Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Updates in bacteriological epidemiology of community-acquired severe acute cholangitis and the effectiveness of metronidazole added routinely to the first-line antimicrobial regimen.

Lee JK, Park CW, Lee SH, Kang HW, Kwon JH, Kim JH, Lim YJ, Kim ES, Koh MS, Lee JH.

J Infect Chemother. 2013 Dec;19(6):1029-34. doi: 10.1007/s10156-013-0616-7. Epub 2013 May 25.

PMID:
23708782
2.

[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].

Kiesslich R, Will D, Hahn M, Nafe B, Genitsariotis R, Mäurer M, Jung M.

Z Gastroenterol. 2003 Jan;41(1):5-10. German.

PMID:
12541165
3.

Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases.

Kumar R, Sharma BC, Singh J, Sarin SK.

J Gastroenterol Hepatol. 2004 Sep;19(9):994-7.

PMID:
15304115
4.

Endoscopic biliary drainage for severe acute cholangitis.

Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, Wong J.

N Engl J Med. 1992 Jun 11;326(24):1582-6.

5.

Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial.

Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, Leung JW, Li AK.

J Antimicrob Chemother. 1995 Jun;35(6):855-64.

PMID:
7559196
6.

Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia.

Uno S, Hase R, Kobayashi M, Shiratori T, Nakaji S, Hirata N, Hosokawa N.

Int J Infect Dis. 2017 Feb;55:81-85. doi: 10.1016/j.ijid.2016.12.018. Epub 2016 Dec 24.

7.

The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens.

Sung YK, Lee JK, Lee KH, Lee KT, Kang CI.

Am J Gastroenterol. 2012 Mar;107(3):473-83. doi: 10.1038/ajg.2011.387. Epub 2012 Feb 14.

PMID:
22334249
8.

Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study.

Sakai Y, Tsuyuguchi T, Kato K, Sugiyama H, Nishikawa T, Takahashi M, Yokosuka O.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):19-25. doi: 10.5414/CP201786.

PMID:
23073141
9.

Endoscopic sphincterotomy and biliary drainage in patients with cholangitis due to common bile duct stones.

Boender J, Nix GA, de Ridder MA, Dees J, Schütte HE, van Buuren HR, van Blankenstein M.

Am J Gastroenterol. 1995 Feb;90(2):233-8.

PMID:
7847292
10.

TG13 antimicrobial therapy for acute cholangitis and cholecystitis.

Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M, Kusachi S, Mayumi T, Miura F, Kiriyama S, Yokoe M, Kimura Y, Higuchi R, Windsor JA, Dervenis C, Liau KH, Kim MH; Tokyo Guideline Revision Committee.

J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):60-70. doi: 10.1007/s00534-012-0572-0. Erratum in: J Hepatobiliary Pancreat Sci. 2013 Apr;20(4):457-8.

PMID:
23340954
11.

Verification of Tokyo Guidelines for diagnosis and management of acute cholangitis.

Fujii Y, Ohuchida J, Chijiiwa K, Yano K, Imamura N, Nagano M, Hiyoshi M, Otani K, Kai M, Kondo K.

J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):487-91. doi: 10.1007/s00534-011-0464-8.

PMID:
22033865
12.

[Perioperative antimicrobial prophylaxis for colonic surgery: Present status in Germany. A prospective multicenter study with and without Metronidazole].

Mittelkötter U, Rau HG, Thiede A, Schildberg FW, Kullmann KH.

Zentralbl Chir. 2001 Oct;126(10):799-804. German.

PMID:
11727192
13.

[Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance].

Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R, Daniello S, Maeurer M, Jung M.

Z Gastroenterol. 2001 Dec;39(12):985-92. German.

PMID:
11753782
14.

Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.

Karachalios GN, Nasiopoulou DD, Bourlinou PK, Reppa A.

Int J Clin Pharmacol Ther. 1996 Dec;34(12):555-7.

PMID:
8996852
15.

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.

Solomkin JS, Reinhart HH, Dellinger EP, Bohnen JM, Rotstein OD, Vogel SB, Simms HH, Hill CS, Bjornson HS, Haverstock DC, Coulter HO, Echols RM.

Ann Surg. 1996 Mar;223(3):303-15.

16.

Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.

Gisbert JP, Gisbert JL, Marcos S, Olivares D, Pajares JM.

Aliment Pharmacol Ther. 2005 Nov 15;22(10):1041-6.

17.

Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.

Mehal WZ, Culshaw KD, Tillotson GS, Chapman RW.

Eur J Gastroenterol Hepatol. 1995 Sep;7(9):841-5.

PMID:
8574715
19.

The role of oral antimicrobials for the management of intra-abdominal infections.

Solomkin JS, Dellinger EP, Bohnen JM, Rostein OD.

New Horiz. 1998 May;6(2 Suppl):S46-52.

PMID:
9654311
20.

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.

Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW.

Inflamm Bowel Dis. 2001 Nov;7(4):301-5.

PMID:
11720319

Supplemental Content

Support Center